Results for this period
Third quarter1 November 2025 to 31 July 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Higher revenue from the Agrochemicals and Agricultural-Related Business and the Chemical Products Business, and lower revenue from Other Businesses. Inventory valuation losses resulting from lower market prices following the entry of generic products for 「アクシーブ」, impairment losses on fixed assets in the Chemical Products Business and restructuring expenses, higher equity-method investment gains, and the change from foreign exchange losses to foreign exchange gains.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 November 2025 to 31 July 2026 |
| Net Sales | ¥141,406 million (YoY +5.1%) |
| Operating profit | ¥7,628 million (YoY -26.7%) |
| Ordinary income | ¥12,205 million (YoY +5.5%) |
| Profit attributable to owners of the parent | ¥5,725 million (YoY -36.7%) |
| Net income per share | ¥47.53 |
| Equity ratio | End of the current fiscal period 61.5 / End of previous period 58.2 |
| Total assets | ¥240,813 million |
| Net assets | ¥154,720 million |
| Full-year earnings forecast | Net Sales ¥175,000 million (YoY +2.7%) / Operating profit ¥2,700 million (YoY -74.4%) / Ordinary income ¥8,500 million (YoY -36.4%) / Profit attributable to owners of the parent ¥4,000 million (YoY -8.7%) |
| Revision to Earnings Forecast | Net Sales Not disclosed → ¥175,000 million / Operating profit Not disclosed → ¥2,700 million / Ordinary income Not disclosed → ¥8,500 million / Profit attributable to owners of the parent Not disclosed → ¥4,000 million |
| Annual Dividend Forecast | ¥24 → ¥24(0.0%) |
| Segment revenue | Agrochemicals and Agricultural-Related Business ¥111,893 million (YoY +3.5%) / Chemical Products Business ¥22,519 million (YoY +19.5%) / Other ¥6,994 million (YoY -6.8%) |
| Segment profit | Agrochemicals and Agricultural-Related Business ¥6,782 million (YoY -32.0%) / Chemical Products Business ¥1,873 million (YoY +31.0%) / Other ¥648 million (YoY +13.7%) |
| Depreciation and amortization | ¥4,317 million |
| Impairment loss | ¥514 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on disposal of fixed assets 8 / Gain on sale of investment securities 3 / Subsidy Income 244 / Insurance proceeds received 1 / Extraordinary loss Losses on disposal of fixed assets 133 / Loss on reduction of fixed assets 244 / Impairment loss 514 / Restructuring Costs 907 |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | No material changes. The number and names of companies newly included in or excluded from the scope of consolidation are not stated. |
| Material subsequent events | The three consolidated subsidiaries Ihara Kensei Kogyo Co., Ltd., Kumika Logistics Co., Ltd. and Nippon Printing Industry Co., Ltd. are scheduled to become wholly owned subsidiaries through a simplified share exchange, with 1 November 2026 as the effective date. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 133,184,612 |
| Treasury Shares at Period-End | 12,712,893 |
| Factors Behind Changes in Business Performance | Higher revenue from the Agrochemicals and Agricultural-Related Business and the Chemical Products Business, and lower revenue from Other Businesses. Inventory valuation losses resulting from lower market prices following the entry of generic products for 「アクシーブ」, impairment losses on fixed assets in the Chemical Products Business and restructuring expenses, higher equity-method investment gains, and the change from foreign exchange losses to foreign exchange gains. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Higher revenue from the Agrochemicals and Agricultural-Related Business and the Chemical Products Business contributed to the increase in revenue. Operating profit decreased due to inventory valuation losses and other factors resulting from lower market prices following the entry of generic products for 「アクシーブ」. Ordinary profit increased due to higher equity-method investment gains and the change from foreign exchange losses to foreign exchange gains. Profit attributable to owners of the parent decreased due to impairment losses on fixed assets, restructuring expenses and other factors.